Related Experiment Video
Updated: Apr 5, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
A New Fungal Diterpene Induces VDAC1-dependent Apoptosis in Bax/Bak-deficient Cells
Li Huang1, Junjie Han2, Danya Ben-Hail3
1From the State Key Laboratory of Biomembrane and Membrane Biotechnology, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China, the University of the Chinese Academy of Sciences, Beijing 100049, China.
Abstract:
The pro-apoptotic Bax and Bak proteins are considered central to apoptosis, yet apoptosis occurs in their absence. Here, we asked whether the mitochondrial protein VDAC1 mediates apoptosis independently of Bax/Bak. Upon screening a fungal secondary metabolite library for compounds inducing apoptosis in Bax/Bak-deficient mouse embryonic fibroblasts, we identified cyathin-R, a new cyathane diterpenoid compound able to activate apoptosis in the absence of Bax/Bak via promotion of the VDAC1 oligomerization that mediates cytochrome c release. Diphenylamine-2-carboxilic acid, an inhibitor of VDAC1 conductance and oligomerization, inhibited cyathin-R-induced VDAC1 oligomerization and apoptosis. Similarly, Bcl-2 overexpression conferred resistance to cyathin-R-induced apoptosis and VDAC1 oligomerization. Silencing of VDAC1 expression prevented cyathin-R-induced apoptosis. Finally, cyathin-R effectively attenuated tumor growth and induced apoptosis in Bax/Bak-deficient cells implanted into a xenograft mouse model. Hence, this study identified a new compound promoting VDAC1-dependent apoptosis as a potential therapeutic option for cancerous cells lacking or presenting inactivated Bax/Bak.
Insights
A new compound, cyathin-R, triggers programmed cell death (apoptosis) by activating the VDAC1 protein, even when key apoptosis proteins Bax and Bak are absent. This offers a potential cancer therapy for cells lacking Bax/Bak.
Area of Science:
- Cell Biology
- Molecular Biology
- Pharmacology
Background:
- The proteins Bax and Bak are crucial for initiating apoptosis, a key cell death pathway.
- Apoptosis can still occur even when Bax and Bak are absent, suggesting alternative mechanisms exist.
Purpose of the Study:
- To investigate if the mitochondrial protein VDAC1 can mediate apoptosis independently of Bax and Bak.
- To identify novel compounds that can induce apoptosis in a Bax/Bak-independent manner.
Main Methods:
- Screening a fungal secondary metabolite library for compounds inducing apoptosis in Bax/Bak-deficient cells.
- Utilizing VDAC1 inhibitors and gene silencing to confirm VDAC1's role.
- Testing the compound's efficacy in a xenograft mouse model.
Main Results:
- Cyathin-R, a novel cyathane diterpenoid, induced apoptosis in Bax/Bak-deficient cells by promoting VDAC1 oligomerization and subsequent cytochrome c release.
- Inhibition of VDAC1 and Bcl-2 overexpression blocked cyathin-R-induced apoptosis.
- VDAC1 silencing prevented cyathin-R-induced apoptosis.
- Cyathin-R reduced tumor growth in a xenograft model.
Conclusions:
- Cyathin-R activates apoptosis through a VDAC1-dependent pathway, independent of Bax and Bak.
- This compound represents a potential therapeutic strategy for cancers with deficient Bax/Bak.
- VDAC1-mediated apoptosis offers a target for novel anti-cancer drug development.
Related Concept Videos
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Antifungal Agents
Apoptosis
Caspases
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

